1 Professor Vlado Perkovic further states, These findings offer great promise in reshaping treatment strategies for individuals at high risk of diabetes-related complications, offering a new avenue for kidney and cardiovascular protection. The FLOW trial was overseen by an academic-led Steering Committee, in partnership with the study sponsor, Novo Nordisk, which also managed trial operations
Orforglipron (LY3502970), a novel, oral non-peptide glucagon-like peptide-1 receptor agonist: a Phase 1b, multicentre, blinded, placebo-controlled, randomized, multiple-ascending-dose study in people with type 2 diabetes
33,34 Moreover, the main treatment for celiac disease, a gluten-free diet, may restrict the intake of vitamin B 6 -rich foods
You're having bloating that seems tied to diet shifts (more fiber, fewer meals) and you tolerate fermented bacteria well
Many countries are launching policies and funding programs to combat obesity, expanding access to medical interventions and raising awareness
Typical SubQ injections doses are small, often around 1 mL or less, unless directed otherwise